original ) (raw )225: Assessment of Biochemical Outcome with Increasing Dose Escalation in Localized Prostate Cancer (PCA) With Precision Image-Guided Radiotherapy (IGRT)
Helene Hovington
Radiotherapy and Oncology, 2016
View PDFchevron_right
Post Intensity-Modulated Radiation Therapy Urinary Function for Prostate Cancer; A Prospective Study
Amirhossein Rahavian
2020
View PDFchevron_right
The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome
Waseet Vance
International Journal of Radiation Oncology*Biology*Physics, 2007
View PDFchevron_right
Prediction of Outcome Following Early Salvage Radiotherapy Among Patients with Biochemical Recurrence After Radical Prostatectomy
Karin Haustermans
European Urology, 2013
View PDFchevron_right
Biochemical outcome following external beam radiation therapy with or without androgen suppression therapy for patients with clinically localized prostate cancer
Clair Beard
International Journal of Radiation Oncology*Biology*Physics, 2000
View PDFchevron_right
Pooled Analysis of High-Dose-Rate Brachytherapy or Stereotactic Body Radiation Therapy Monotherapy for Intermediate-Risk Prostate Cancer
Donald Fuller
International Journal of Radiation Oncology*Biology*Physics, 2015
View PDFchevron_right
Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial
George Starkschall
International Journal of Radiation Oncology*Biology*Physics, 2002
View PDFchevron_right
PSA based review of adjuvant and salvage radiation therapy vs. observation in postoperative prostate cancer patients
Peter Schiff
International Journal of Cancer, 2000
View PDFchevron_right
Postoperative Radiation Therapy for Pathologically Advanced Prostate Cancer After Radical Prostatectomy
Hein Van Poppel
European Urology, 2012
View PDFchevron_right
Who can benefit from postoperative radiotherapy following biochemical recurrence after radical prostatectomy?—looking for the “Rosetta Stone” of prostate cancer
Alessandro Volpe
AME Medical Journal, 2018
View PDFchevron_right
Predictive Factors for Urinary Toxicity from a Multi-Center Trial of Stereotactic Body Radiation Therapy for Prostate Cancer
Najeeb Mohideen
International Journal of Radiation Oncology*Biology*Physics, 2018
View PDFchevron_right
Predictors of acute urinary symptom flare following stereotactic body radiation therapy (SBRT) in the definitive treatment of localized prostate cancer
Anatoly Dritschilo
Acta Oncologica, 2017
View PDFchevron_right
5-Year Outcomes of a Prospective Phase 1/2 Study of Accelerated Hypofractionated Radiation Therapy to the Prostate Bed
Alexandre Mamedov
Practical radiation oncology, 2019
View PDFchevron_right
Dose response in prostate cancer with 8-12 years follow-up
Eric Horwitz
International Journal of Radiation Oncology*Biology*Physics, 2001
View PDFchevron_right
Post Radiotherapy Prostate Biopsies: What Do They Really Mean? 5 Year Results for 498 Patients
Juanita Crook
J Urol, 1999
View PDFchevron_right
Post-prostatectomy radiation therapy: Consensus guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group
Jeremy Millar
Radiotherapy and Oncology, 2008
View PDFchevron_right
Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995
Jeff Michalski
International Journal of Radiation Oncology*Biology*Physics, 2003
View PDFchevron_right
Lack of radiation dose response for patients with low-risk clinically localized prostate cancer: a retrospective analysis
Clair Beard
International Journal of Radiation Oncology*Biology*Physics, 2002
View PDFchevron_right
11 C-Choline PET-Guided Salvage Radiation Therapy for Isolated Pelvic and Para-aortic Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Low Rates of Adverse Effects
Lance A Mynderse
International Journal of Radiation Oncology*Biology*Physics, 2017
View PDFchevron_right
Late Toxicity After Intensity-Modulated Radiation Therapy for Localized Prostate Cancer: An Exploration of Dose–Volume Histogram Parameters to Limit Genitourinary and Gastrointestinal Toxicity
Stanley Liauw
International Journal of Radiation Oncology*Biology*Physics, 2012
View PDFchevron_right
Interval to Biochemical Failure Predicts Clinical Outcomes in Patients With High-Risk Prostate Cancer Treated by Combined-Modality Radiation Therapy
Mark Shilkrut
International Journal of Radiation Oncology*Biology*Physics, 2013
View PDFchevron_right
The relationship between the biochemical control outcomes and the quality of planning of high-dose rate brachytherapy as a boost to external beam radiotherapy for locally and locally advanced prostate cancer using the RTOG-ASTRO Phoenix definition
Paulo E Novaes , Joao Salvajoli
International Journal of Medical Sciences, 2000
View PDFchevron_right
Prostate Position Variability and Dose-Volume-Histograms in Radiotherapy for Prostate Cancer with Full and Empty Bladder
Michael Pinkawa
International Journal of Radiation Oncology*Biology*Physics, 2005
View PDFchevron_right
Twenty-four-month postradiation prostate biopsies are strongly predictive of 7-year disease-free survival
Juanita Crook
Cancer, 2009
View PDFchevron_right
High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients
Yoshiya Yamada
International Journal of Radiation Oncology*Biology*Physics, 2002
View PDFchevron_right
Patient-Assessed Late Toxicity Rates and Principal Component Analysis After Image-Guided Radiation Therapy for Prostate Cancer
Juanita Crook
International Journal of Radiation Oncology*Biology*Physics, 2007
View PDFchevron_right
Recommendations for Post-Prostatectomy Radiation Therapy in the United States Before and After the Presentation of Randomized Trials
Ronald Chen
The Journal of Urology, 2011
View PDFchevron_right
Assessment of the American Joint Committee on Cancer Staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification me
Eric Horwitz
Cancer, 2012
View PDFchevron_right
A Comparison between Patient- and Physician-Reported Late Radiation Toxicity in Long-Term Prostate Cancer Survivors
Lukas Stalpers
Cancers
View PDFchevron_right
Patient-reported outcomes following stereotactic body radiation therapy for clinically localized prostate cancer
Anatoly Dritschilo
Radiation Oncology, 2014
View PDFchevron_right